Cargando…
Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development
Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT associated gene, PMP22, the technological advancement in molecular genetics and gene technology has allowed...
Autores principales: | Juneja, Manisha, Burns, Joshua, Saporta, Mario A, Timmerman, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327864/ https://www.ncbi.nlm.nih.gov/pubmed/30018047 http://dx.doi.org/10.1136/jnnp-2018-318834 |
Ejemplares similares
-
Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan
por: Yoshimura, Akiko, et al.
Publicado: (2019) -
DNAJB2‐related Charcot‐Marie‐Tooth disease type 2: Pathomechanism insights and phenotypic spectrum widening
por: Saveri, Paola, et al.
Publicado: (2022) -
Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021) -
Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy
por: Tucci, Arianna, et al.
Publicado: (2014) -
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
por: Fridman, V, et al.
Publicado: (2015)